PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555732
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555732
Vascular Closure Devices Market size was valued at USD 1,435.67 Million in 2023, expanding at a CAGR of 5.4% from 2024 to 2032.
The Vascular Closure Devices Market, which involves devices used to seal vascular access sites after catheter-based procedures, is expanding due to the growing prevalence of cardiovascular diseases and the increasing number of minimally invasive procedures. The rising incidence of conditions such as coronary artery disease, affecting approximately 18 million adults in the U.S. according to the American Heart Association, is boosting the demand for effective vascular closure solutions. Advancements in device technology, including improvements in safety and ease of use, are also contributing to market growth. However, challenges such as the high cost of advanced devices and potential complications related to device use can restrain market expansion. Opportunities exist in the form of increasing investments in R&D for novel device innovations and the expanding adoption of vascular closure devices in emerging markets. For instance, the World Health Organization reports that cardiovascular diseases are the leading cause of death globally, underscoring the critical need for effective closure solutions in managing vascular access.
Vascular Closure Devices Market- Market Dynamics
Rising Adoption of Minimally Invasive Procedures Boosting Demand for Vascular Closure Devices
The rising adoption of minimally invasive procedures is significantly boosting the demand for vascular closure devices, which are essential for sealing access sites after such interventions. According to the American College of Cardiology, minimally invasive cardiac procedures have increased by over 20% in the past decade, driven by advancements in technology and patient preference for less invasive options. The World Health Organization also highlights that minimally invasive techniques contribute to shorter recovery times and reduced hospital stays, further encouraging their use. This growing trend underscores the need for effective vascular closure solutions to ensure safe and efficient recovery following catheter-based procedures. Additionally, the increased focus on improving patient outcomes and reducing complications associated with vascular access points is driving innovation and adoption of these devices in healthcare settings worldwide.
Vascular Closure Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.4% over the forecast period (2024-2032)
Based on Type segmentation, Active Approximators were predicted to show maximum market share in the year 2023
Based on Material segmentation, Collagen-Based Devices was the leading type in 2023
Based on Procedure segmentation, Interventional Cardiology was the leading type in 2023
Based on Access Site segmentation, Femoral Access was the leading type in 2023
Based on end-user segmentation, Hospitals were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Vascular Closure Devices Market is segmented based on Type, Material, Procedure, Access Site, End User, and Region.
The market is divided into three categories based on Type: Active Approximators, Passive Approximators, and External Hemostasis Devices. Active Approximators hold the highest priority in the Vascular Closure Devices Market due to their effectiveness in achieving precise vessel closure. Passive Approximators are next for their simpler application, while External Hemostasis Devices are less prioritized due to their broader but less targeted use.
The market is divided into four categories based on Material: Collagen-Based Devices, Suture-Based Devices, Metallic Clips, and Polymer-Based Devices. Collagen-based devices are the highest priority in the Vascular Closure Devices Market due to their natural integration and effectiveness in sealing. Suture-based devices are followed for their reliability, while Metallic Clips and Polymer-Based Devices are secondary, offering specific advantages in targeted applications.
Vascular Closure Devices Market- Geographical Insights
The Vascular Closure Devices Market shows diverse growth across regions, with North America at the forefront thanks to its sophisticated healthcare infrastructure, high rates of cardiovascular diseases, and substantial investments in medical technology. The United States, in particular, shows strong demand driven by a high volume of minimally invasive procedures and a well-established healthcare system. Europe follows closely, supported by growing healthcare expenditures and increasing adoption of advanced medical devices in countries like Germany, France, and the UK. The Asia-Pacific region is experiencing rapid growth, driven by expanding healthcare infrastructure, rising incidence of cardiovascular conditions, and increasing access to advanced medical technologies in countries such as China and India. Latin America and the Middle East & Africa are also emerging markets, with potential growth fueled by improving healthcare systems and increasing awareness of advanced vascular closure solutions.
The competitive landscape of the Vascular Closure Devices Market is marked by the presence of several key players focused on technological innovation, strategic partnerships, and market expansion. Leading companies such as Terumo Corporation, Abbott Laboratories, and Medtronic dominate the market, leveraging their extensive research and development capabilities to introduce advanced vascular closure solutions. These companies often engage in strategic collaborations and acquisitions to broaden their product portfolios and enhance their market presence. Additionally, emerging players are entering the market with novel technologies and cost-effective solutions, aiming to capture a share of the growing demand. The competitive environment is also shaped by the need to meet stringent regulatory standards and ensure the safety and efficacy of vascular closure devices, which drives continuous innovation and improvement.
In October 2023, Reckitt and Mondi announced the launch of a new packaging made of paper which is made of 75% less plastic and will be used for packaging Finish dishwater tablets. The move is expected to eliminate the use of almost 2,000 tonnes of plastic annually once it is completely in action